Tubal patency after clinical treatment of unruptured ectopic pregnancy.

OBJECTIVE

To evaluate tubal patency using hysterosalpingography after clinical treatment of tubal pregnancy.

METHOD: Of 80 patients who underwent hysterosalpingography after clinical treatment of tubal pregnancy from April 1994 to February 2002, 30 were treated with a single 50 mg/m(2) dose of methotrexate intramuscularly (n=30) and 50 were followed up expectantly.

RESULTS

Patency of the ipsilateral tube was 84% after methotrexate treatment and 78% after expectant management. In addition, contralateral tubal patency was 97% after methotrexate treatment and 92% after expectant management. There were no statistically significant differences between the groups.

CONCLUSION

Findings from this study suggest similar tubal patency rates after methotrexate treatment and expectant management.